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Abstract
Background: Perioperative neuropathic pain is under-recognized and
often undertreated. Chronic pain may develop after any routine surgery,
but it can have a far greater incidence after amputation, thoracotomy or
mastectomy. The peak noxious barrage due to the neural trauma
associated with these operations may be reduced in the perioperative
period with the potential to reduce the risk of chronic pain.
Databases and data treatment: A systematic review of the evidence for
perioperative interventions reducing acute and chronic pain associated
with amputation, mastectomy or thoracotomy.
Results: Thirty-two randomized controlled trials met the inclusion
criteria. Gabapentinoids reduced pain after mastectomy, but a single dose
was ineffective for thoracotomy patients who had an epidural.
Gabapentinoids were ineffective for vascular amputees with pre-existing
chronic pain. Venlafaxine was associated with less chronic pain after
mastectomy. Intravenous and topical lidocaine and perioperative EMLA
(eutectic mixture of local anaesthetic) cream reduced the incidence of
chronic pain after mastectomy, whereas local anaesthetic infiltration
appeared ineffective. The majority of the trials investigating regional
analgesia found it to be beneficial for chronic symptoms. Ketamine and
intercostal cryoanalgesia offered no reduction in chronic pain. Total
intravenous anaesthesia (TIVA) reduced the incidence of
post-thoracotomy pain in one study, whereas high-dose remifentanil
exacerbated chronic pain in another.
Conclusions: Appropriate dose regimes of gabapentinoids, antidepres-
sants, local anaesthetics and regional anaesthesia may potentially reduce
the severity of both acute and chronic pain for patients. Ketamine was not
effective at reducing chronic pain. Intercostal cryoanalgesia was not
effective and has the potential to increase the risk of chronic pain. TIVA
may be beneficial but the effects of opioids are unclear.
1. Background and objective
Chronic pain may occur in a minority of patients after
minor operations, but the incidence is much greater
after procedures that involve major nerve injury or
transection. This systematic review examines the
impact of specific interventions on the management of
perioperative pain and associated chronic pain in
high-risk operations such as amputation (50–80%),
mastectomy (20–40%) and thoracotomy (30–50%;
Kehlet et al., 2006; Macrae, 2008). Neuropathic pain is
typically due to a damaged or dysfunctional nervous
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system (Woolf and Salter, 2000; Macintyre and Schug,
2007; Gray, 2008) and it may be characterized by
sharp, shooting or burning sensations associated with
sensory loss and paradoxical hypersensitivity (Macrae,
2008). The underlying pathophysiological processes
are highly complex, but involve the interaction of the
immune and nervous systems, which results in
peripheral and central sensitization (Scholz andWoolf,
2007; Harvey and Dickenson, 2008). Neuropathic
changes are traditionally associated with chronic pain,
whereas acute pain has been considered as a protec-
tive nociceptive process. However, acute neuropathic
pain is now also considered to be an eminently treat-
able but significantly under-recognized condition
(Dworkin et al., 2007; Gray, 2008). The true incidence
of acute neuropathic pain after surgery is uncertain
(Gray, 2008), but the incidence of acute neuropathic
phantom limb pain after amputation is greater than
50% (Jaeger and Maier, 1992; Nikolajsen et al., 1997).
In addition, severe post-operative pain is associated
with a far higher risk of developing chronic pain
(Kalkmann et al., 2003; Bisgaard et al., 2005; Kehlet
et al., 2006; Hanley et al., 2007). Therefore, prompt,
aggressive management has the potential to make a
substantial difference in the short term and, perhaps
even more importantly in the long term as well before
symptoms become entrenched. However, if periopera-
tive pain management regimes only incorporate
opioids, non-steroidal anti-inflammatory drugs
(NSAIDs) and regional analgesia, then patients with
acute neuropathic pain may be undertreated and
therefore at significantly increased risk of developing
chronic pain. Chronic pain is considered to be a
complex biopsychosocial condition and a long-term
multidisciplinary approach to management may be
required for many cases. The therapeutic options
available for established chronic pain have substantial
limitations and problematic side effects; therefore, pre-
ventative techniques are of particular importance.
2. Databases and data treatment
2.1 Search strategy
A literature search was carried out using Medline
(1946–January 2014), Embase (1974–January 2014)
and the Cochrane Library. The research question was,
‘What is the evidence for the use of specific therapeu-
tic interventions in the management of perioperative
pain in procedures that have a high risk of chronic
pain and whether these interventions reduce chronic
post-surgical pain?’ We used a combination of key-
words and subject headings. The subjects of interest
included amputation, mastectomy, thoracotomy, peri-
operative, pain, neuropathic, chronic pain, pre-
emptive, epidural, regional and the relevant drug
names and classes. All subject headings were exam-
ined for relevant terms that are related to the types of
operation performed and the types of intervention.
Articles were limited to randomized controlled trials
(RCTs) in adult human participants. Additional studies
were identified by manually tracking references from
published papers. On some occasions, where a manu-
script was unavailable, the authors were contacted
directly.
Studies were also excluded in which subjects were
recruited after the perioperative period and those with
follow-up periods of less than 2 months were
excluded. Studies with high risk of bias as assessed by
the Cochrane Risk of Bias Tool (Higgins and Green,
2011) were excluded. Additional studies were identi-
fied by manually tracking references from published
papers. On some occasions, where a manuscript was
unavailable, the authors were contacted directly.
2.2 Article selection
All of the trials were reviewed independently by each
of the authors and consensus was reached as to the
inclusion and interpretation of each individual trial.
This review focused only on surgical procedures
associated with a high incidence of chronic pain:
amputation, mastectomy and thoracotomy. Studies
investigating acute pain and chronic pain were ana-
lysed, whereas studies in which subjects were
recruited after the perioperative week and those with
follow-up periods of less than 2 months were
excluded. Once all of the trials were collated and ana-
lysed, an assessment was made of the potential to
perform a meta-analysis of the quantitative efficacy of
specific interventions.
Database
• Medline (1946–January 2014), Embase (1974–
January 2014) and the Cochrane Library.
• Thirty-two randomized controlled trials met the
inclusion criteria.
What does this review add?
• Appropriate dose regimes of gabapentinoids,
antidepressants, local anaesthetics and regional
anaesthesia may potentially reduce pain.
• Ketamine and intercostal cryoanalgesia were not
effective at reducing chronic pain.
• Total intravenous anaesthesia may be beneficial.
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3. Results
The combined literature search identified 598 records
and a further 6 additional records were identified
through the manual tracking of references. After the
duplicates were removed, 331 records were screened,
and of these, 252 excluded as being clearly irrelevant.
A total of 79 records were therefore assessed for eligi-
bility and of these 47 were excluded (the most
common reasons were as follows: not RCT, inappro-
priate study design, high risk of bias, inadequate size,
not related to pain and/or chronic pain not assessed).
Thirty-two trials met the eligibility criteria and were
included in the qualitative analysis.
3.1 Study characteristics
Of the 32 trials, 5 (16%) studied amputation, 17
(53%) studied thoracotomy and 10 (31%) studied
mastectomy. Details of all studies are summarized in
Tables 1 and 2. The mean sample size was 89 (±12 SD)
subjects (range 36–343). The mean duration of patient
follow-up in the trials was 7 (±1 SD) months following
the surgical procedure (range 2–15). Four of the trials
had more than two study arms and (reflecting the
complexity of clinical practice) 13 trials incorporated
multiple interventions within the same study. The
outcome measures varied between studies; the visual
analogue scale (VAS; 0–100 mm) was used in 22 trials;
a version of the numerical rating scale (NRS; 0–10)
was used in 20 trials; and the verbal rating score
(0–3 = nil/mild/moderate/severe) was used in four
trials. Pain at rest and movement was assessed in nine
trials and quantitative sensory testing was used in
eight trials. A multidimensional score such as the
McGill Pain Questionnaire was used in nine trials.
3.2 Interventions studied
Five of the trials studied the impact of the gabapenti-
noids and the dose regimen and duration of therapy
was different in every trial (Fassoulaki et al., 2002,
2005; Nikolajsen et al., 2006; Amr and Yousef, 2010;
Kinney et al., 2012). One trial incorporated the anti-
depressant venlafaxine (Amr and Yousef, 2010). Six
trials studied the impact of ketamine; two consisted of
intravenous ketamine without epidural analgesia
(Hayes et al., 2004; Dualé et al., 2009), two consisted
of intravenous ketamine in addition to epidural anal-
gesia (Joseph et al., 2012; Mendola et al., 2012) and
two examined the effect of epidural ketamine (Wilson
et al., 2008; Ryu et al., 2011). Six trials studied the
impact of cryoanalgesia in thoracotomy. Of these, two
trials compared cryoanalgesia against control treat-
ment with intravenous opioids (Gwak et al., 2004;
Sepsas et al., 2013), one trial compared cryoanalgesia
to epidural analgesia (Ju et al., 2008), two trials com-
pared the effect of cryoanalgesia versus placebo in
thoracotomy patients who all had epidural analgesia
(Yang et al., 2004; Mustola et al., 2011) and one trial
compared cryoanalgesia to non-divided intercostal
muscle flap (Lu et al., 2013). Six trials examined the
impact of local anaesthetic; of these, three incorpo-
rated infiltration with differing doses of ropivacaine in
mastectomy (Albi-Feldzer et al., 2013; Baudry et al.,
2008; Vigneau et al., 2011), one trial studied the
impact of lidocaine infiltration in thoracotomy
patients that already had a thoracic epidural in situ
(Cerfolio et al., 2003), one trial examined the effect of
intravenous lidocaine (Grigoras et al., 2012) and the
remaining one assessed the impact of topical EMLA
(eutectic mixture of local anaesthetic) cream in mas-
tectomy patients (Fassoulaki et al., 2000). The impact
of regional analgesia was studied in eight trials (two
amputation, two mastectomy and four thoracotomy).
Three trials examined whether commencing an epi-
dural prior to thoracotomy was better than commenc-
ing it at the end of the procedure (Obata et al., 1999;
Ochroch et al., 2002; Senturk et al., 2002). One trial
compared pre-surgical epidural and low-dose intraop-
erative remifentanil infusion versus post-surgical epi-
dural and high-dose intraoperative remifentanil
infusion (Salengros et al., 2010). One trial compared
epidural analgesia to epidural saline plus standard
management of thoracotomy pain (Nikolajsen et al.,
1997). Two trials examined the impact of paraverte-
bral block for mastectomy patients (Kairaluoma et al.,
2006; Ibarra et al., 2011). One trial had five study
arms that studied epidural therapy, fentanyl patient-
controlled analgesia (PCA) and standard therapy
before, during and after amputation (Karanikolas
et al., 2011). A single trial examined the impact of
total intravenous anaesthesia (TIVA) versus inhala-
tional anaesthesia in thoracotomy patients with tho-
racic epidurals in situ (Song et al., 2012).
3.3 Study ﬁndings
3.3.1 Gabapentinoids and antidepressants
In patients after mastectomy, gabapentinoids reduced
acute pain in three trials (Fassoulaki et al., 2002, 2005;
Amr and Yousef, 2010). Gabapentinoids also reduced
the overall incidence of chronic pain in one
(Fassoulaki et al., 2002) and the incidence of chronic
burning pain in another (Fassoulaki et al., 2005).
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Table 1 Randomized controlled trials of therapeutic interventions to reduce acute and chronic postsurgical pain.
Δ Ac Δ Chr Study Intervention Op Size RoB Outcomes
1 Y Y Fassoulaki et al.
(2002)
Mexiletine 600 mg/day
versus gabapentin
1200 mg/day versus
placebo, for 10
days.
M 75 + Gabapentin and mexiletine reduced VAS scores versus control over
ﬁrst postop week (by clinically and statistically meaningful
amounts). Gabapentin and mexiletine reduced daily oral analgesic
use versus control over ﬁrst postop week (codeine: 65, 55 and
113 mg, respectively; paracetamol: 2.6, 2.3 and 4.9 g, respectively;
p < 0.05).
No difference in overall incidence of chronic pain at 3 months
(gabapentin 54%, mexiletine 45%, control 58%). Burning pain less
frequent at 3 months (gabapentin 5%, mexiletine 5%, control 29%,
p = 0.033).
2 Y Y Fassoulaki et al.
(2005)
Gabapentin
1600 mg/day,
ropivacaine
inﬁltration and
topical local
anaesthesia cream
versus placebo
M 50 + Gabapentin and local anaesthetic reduced VAS scores versus control
over ﬁrst 3 days postop (by clinically and statistically meaningful
amounts). Gabapentin and local anaesthetic reduced daily oral
analgesic use versus control (paracetamol/codeine: 1.0 tablets vs.
4.4 tablets; p = 0.02)
Gabapentin and local anaesthetic reduced incidence of chronic pain
at 3 months (45% vs. 82%; p = 0.03) although not statistically
signiﬁcant at 6 months (30% vs. 57%; p = 0.15).
3 − N Nikolajsen et al.
(2006)
Gabapentin versus
placebo for 30 days.
300 up to
2100 mg/day. All
patients received
perioperative
epidural analgesia.
A 41 ? Acute pain was not assessed.
Gabapentin had no effect on incidence of phantom limb pain in these
vascular patients at 1 month (gabapentin 55%, control 53%;
p = 0.88) or at 6 months (gabapentin 59%, control 50%; p = 0.59).
Low intensity of phantom limb pain at 6 months in both groups VAS:
(gabapentin: 10 out of 100, control: 7.5 out of 100; p = 0.56).
Opioid consumption was not signiﬁcantly different between the
two groups.
Large proportion of patients had chronic pain before amputation
(median VNRS: gabapentin: 8 out of 10 and control: 8 out of 10).
Longer duration of pre-amputation pain in the treatment group.
Longer duration of epidural infusion in the control group
(gabapentin: 73 h, control: 95 h; p = 0.01). Appears underpowered
and baseline group differences.
4 N N Kinney et al.
(2012)
Single dose of
gabapentin 600 mg
preoperatively
versus placebo. All
patients received
perioperative
epidural analgesia.
T 120 ? Single dose of gabapentin did not improve acute post-thoracotomy
pain scores (VNRS out of 10) versus control in patients already
receiving epidural analgesia (gabapentin: day 1 = 3.1, day 2 = 2.5;
control: day 1 = 2.9, day 2 = 2.5; p > 0.05). There was no difference
in analgesic use.
Single dose of gabapentin did not change incidence of chronic
post-thoracotomy pain versus control in patients already receiving
epidural analgesia (gabapentin: 70%, control: 66%; p = 0.72). No
other quantitative measure of chronic pain at 3 months
(insufﬁciently detailed assessment at 3 months).
5 Y Y Amr and Yousef
(2010)
Venlafaxine
37.5 mg/day versus
gabapentin
300 mg/day versus
placebo for 10 days
M 150 ? Gabapentin reduced VAS after movement by clinically signiﬁcant
amounts daily from day 2 to day 10 (p = 0.003). Venlafaxine
reduced VAS after movement by clinically signiﬁcant amounts daily
from day 8 to day 10 (p = 0.002). Analgesic consumption was
reduced by clinically and statistically signiﬁcant amounts for
gabapentin versus control every day from days 0–10.
At 6 months, venlafaxine (but not gabapentin) reduced the incidence
of burning pain by clinically and statistically signiﬁcant amounts
(venlafaxine = 2%, gabapentin = 12%, control = 22%; p = 0.0018).
At 6 months, venlafaxine (but not gabapentin) reduced the incidence
of stabbing/pricking pain by clinically and statistically signiﬁcant
amounts (venlafaxine = 14%, gabapentin = 32%, control = 40%;
p < 0.05).
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Table 1 (continued)
Δ Ac Δ Chr Study Intervention Op Size RoB Outcomes
6 Y N Dualé et al. (2009) Ketamine bolus
(1 mg/kg) and
infusion (1 mg/kg/h)
for 24 h. No
regional technique
except single-dose
intrapleural
ropivacaine.
T 80 + Ketamine reduced aggregated VAS (area under curve) at 24 h versus
control (ketamine = 73, control = 88; p = 0.039). Morphine
consumption in ﬁrst 24 h was not signiﬁcantly different
(ketamine = 37 mg, control = 41 mg; p = 0.068). At 48 h,
aggregated VAS (area under curve) was not signiﬁcantly different
(ketamine = 69, control = 73; p = 0.672).
At 4 months, there was no difference in any measures of pain or
analgesic consumption. The incidence of ongoing pain was the
same for both ketamine and control groups (ketamine = 24%,
control = 34%; p = 0.325).
7 N N Hayes et al. (2004) Ketamine bolus then
infusion
0.15 mg/kg/h for
72 h
A 45 + On day 3, the incidence of phantom limb pain was no different
(ketamine = 65%, control = 45%; p = 0.34), but stump pain was
higher for the ketamine group (ketamine = 95%, control = 65%;
p = 0.04).
On day 6, the incidence of phantom limb pain was no different
(ketamine = 55%, control = 50%; p = 1.0) and stump pain was no
different (ketamine = 80%, control = 65%; p = 0.48).
VNRS scores were not signiﬁcantly different at day 3, day 6 or at 6
months for phantom or stump pain.
At 6 months, the incidence of phantom limb pain was not signiﬁcantly
different between groups (ketamine = 47%, control = 71%; p = 0.28)
and the incidence of stump pain was not signiﬁcantly different
(ketamine = 47%, control = 35%; p = 0.72). Appears underpowered.
8 N N Mendola et al.
(2012)
Epidural
levobupivacaine
± intravenous
S+ ketamine
infusion
T 66 ? S+ ketamine had no impact on VNRS during the acute post-operative
period days 0–3. However, S+ ketamine reduced the number of
patients requiring supplemental epidural boluses in the ﬁrst 48 h
(day 0: S+ ketamine = 25%, control = 50%; p = 0.04; day 1: S+
ketamine = 22%, control = 53%; p = 0.01; day 2: S+ ketamine = 22%,
control = 23%; p = 0.9; day 3: S+ ketamine = 3%, control = 7%;
p = 0.5).
At 6 months, S+ ketamine infusion had no impact on the incidence of
chronic pain (VNRS > 3: S+ ketamine = 3.4%, control = 0%; p = 0.46;
NPSI > 1: S+ ketamine = 55%, control = 39%; p = 0.23).
9 N N Joseph et al.
(2012)
Epidural ropivacaine
± intravenous
ketamine infusion
T 60 + Ketamine offered no clinically or statistically signiﬁcant beneﬁt on
pain at rest or when coughing during the ﬁrst 48 h. There was no
clinically or statistically signiﬁcant difference in rescue analgesic
consumption or epidural ropivacaine consumption over the ﬁrst
48 h.
At 3 months, ketamine made no difference to VNRS at rest or with
abduction (rest: ketamine VNRS = 1.1, control VNRS = 0.3;
p = 0.385; abduction: ketamine VNRS = 1.3, control VNRS = 1.1,
p = 0.589) or to analgesic consumption. Relatively large proportion
lost to follow-up at 3 months.
10 Y N Wilson et al.
(2008)
Epidural bupivacaine
± epidural
ketamine infusion
(vs. placebo)
A 53 + Ketamine was associated with lower VAS than control during the ﬁrst
48–72 h (ketamine = 0 mm, control = 17 mm; p = 0.03) and with
less epidural top ups (ketamine = 1.8, control = 3.5; p = 0.04).
Mean epidural infusion rate and duration was the same for both
groups.
At 12 months, ketamine had no signiﬁcant impact on the incidence of
stump or phantom pain (stump pain: ketamine = 21%,
control = 33%; p = 0.68; phantom pain: ketamine = 50%,
control = 40%; p = 0.87).
Recruitment was stopped after only 35 patients due to unfavourable
interim analysis.
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Table 1 (continued)
Δ Ac Δ Chr Study Intervention Op Size RoB Outcomes
11 − N Ryu et al. (2011) Epidural
levobupivacaine and
fentanyl ± epidural
ketamine
T 133 + Acute pain was not assessed, although, at 2 weeks, epidural
ketamine had no signiﬁcant impact on median VAS (rest:
ketamine = 25, control = 25; p = 0.73; movement: ketamine = 50,
control = 50; p = 0.54).
At 3 months, epidural ketamine had no signiﬁcant impact on the
incidence of chronic pain (rest: ketamine = 51%, control = 43%;
p = 0.35; movement: ketamine = 68%, control = 74%; p = 0.46).
12 N N Ju et al., (2008) Epidural analgesia
versus intercostal
nerve cryoanalgesia
and morphine PCA
T 114 ? Cryoanalgesia had no statistically signiﬁcant impact on acute VNRS
during ﬁrst 72 h compared with control (data not shown in
publication).
At 12 months, cryoanalgesia had no signiﬁcant impact on the
incidence of chronic pain (cryoanalgesia = 56%, control = 42%;
p = 0.21) but it did increase the incidence of allodynia
(cryoanalgesia = 15%, control = 0%; p = 0.03) and it increased
interference with daily life (cryoanalgesia = 33%, control = 8%;
p = 0.01).
13 N N Yang et al. (2004) Epidural anaesthesia
± intercostal
nerve cryoanalgesia
T 80 ? Cryoanalgesia had no impact on VAS at rest during the ﬁrst
post-operative week. It had no impact on VAS with movement
during the ﬁrst 6 post-operative days. Cryoanalgesia reduced VAS
on the seventh day by a statistically signiﬁcant amount, although
this was not necessarily clinically signiﬁcant (exact data not
described).
At 6 months, cryoanalgesia had no signiﬁcant impact on incidence of
chronic pain (cryoanalgesia = 40%, control = 30%; p = 0.482) or
VNRS (cryoanalgesia: rest VNRS = 2, movement VNRS = 2; control:
rest VNRS = 1.8, movement VNRS = 2; p > 0.05).
14 N N Mustola et al.
(2011)
Epidural anaesthesia
± intercostal
nerve cryoanalgesia
T 42 ? Cryoanalgesia had no beneﬁt during the ﬁrst post-operative week.
Pain scores (VAS or VNRS) were recorded 22 times during the ﬁrst
post-operative week (too many secondary endpoints). There was a
trend for worse pain scores with cryoanalgesia, which reached
statistical signiﬁcance on two occasions.
At 6 months, cryoanalgesia had no signiﬁcant impact on incidence of
chronic pain during exercise (cryoanalgesia = 25%, control = 10%;
statistical data not shown) and no statistically signiﬁcant impact on
VAS (cryoanalgesia: rest VAS = 6.3, movement VAS = 19.3; control:
rest VAS = 2.2, movement VAS = 7.6; p > 0.05). Trial appears
underpowered.
15 ? N Sepsas et al.
(2013)
Intercostal nerve
cryoanalgesia
versus control
T 50 ? Cryoanalgesia reduced rest pain during the ﬁrst week
post-operatively by statistically signiﬁcant amounts. During the ﬁrst
week, VNRS scores were obtained 13 times. During the ﬁrst 2
months, VNRS was obtained a total of 16 times and at every single
time; cryoanalgesia had a statistically signiﬁcant beneﬁt over
control.
At 2 months, cryoanalgesia had a statistically signiﬁcant impact on
VNRS, but this did not appear clinically signiﬁcant (cryoanalgesia
VNRS = 0, control VNRS = 0.25; p = 0.01). There was also a
statistically signiﬁcant reduction in percentage of patients requiring
analgesics at 2 months (cryoanalgesia = 0%, control = 72%;
p < 0.0001). Outcome data appear highly inconsistent with other
cryoanalgesia trials.
16 N N Gwak et al. (2004) Fentanyl
PCA ± intercostal
nerve cryoanalgesia
T 50 ? Cryoanalgesia had no impact on acute pain VAS or analgesic
consumption during the ﬁrst post-operative week compared with
control (data shown graphically).
At 6 months, cryoanalgesia had no signiﬁcant impact on the
incidence of chronic pain compared with control
(cryoanalgesia = 28%, control = 44%, p = NS).
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Table 1 (continued)
Δ Ac Δ Chr Study Intervention Op Size RoB Outcomes
17 N N Lu et al. (2013) Intercostal nerve
cryoanalgesia
versus non-divided
intercostal muscle
ﬂap (NIMF)
T 160 + Cryoanalgesia had no statistically or clinically signiﬁcant impact on
daily VNRS or daily analgesic consumption during the ﬁrst
postoperative week compared with NIMF technique patients.
At 12 months, cryoanalgesia was associated with higher VNRS
(cryoanalgesia = 3.2, NIMF = 1.3; p < 0.01)
18 N N Cerfolio et al.
(2003)
Subcutaneous
inﬁltration of
lidocaine versus
saline (all patients
had epidural)
T 119 + Lidocaine inﬁltration had no signiﬁcant impact on acute pain VNRS or
VAS during the ﬁrst 3 post-operative days.
At 12 months, lidocaine inﬁltration had no signiﬁcant impact on VNRS
(lidocaine = 1, control = 0.85; p = 1.0).
19 ? N Vigneau et al.
(2011)
Ropivacaine wound
inﬁltration versus
isotonic saline
M 46 + Ropivacaine inﬁltration reduced acute pain VAS signiﬁcantly during
the ﬁrst 6 h post-operatively, but had no signiﬁcant impact for the
remainder of the ﬁrst 3 post-operative days.
At 2 months, ropivacaine inﬁltration had no signiﬁcant impact on VAS
(ropivacaine: rest VAS = 9.1, movement VAS = 20.2; control: rest
VAS = 4.4, movement VAS = 21.4; p > 0.05) or quality of life score.
20 ? N Albi-Feldzer et al.
(2013)
Ropivacaine wound
inﬁltration versus
isotonic saline
M 236 + Ropivacaine inﬁltration reduced acute pain VAS signiﬁcantly at rest
and with movement during the ﬁrst 90 min post-operatively, but
there was no signiﬁcant difference in VAS after that.
At 12 months, ropivacaine inﬁltration had no signiﬁcant impact on
Brief Pain Inventory (BPI) score (ropivacaine = 1.97, control = 1.7;
p = 0.41). A similar proportion of patients reported BPI 3 or above
in both groups (ropivacaine = 33.3%, control = 26.9%; p = 0.37).
21 N N Baudry et al.
(2008)
Ropivacaine wound
inﬁltration versus
isotonic saline
M 81 ? Ropivacaine inﬁltration had no signiﬁcant impact on acute pain VAS or
analgesic consumption compared to the control group.
At 15 months after surgery, ropivacaine inﬁltration had no signiﬁcant
impact on the incidence of chronic pain (ropivacaine = 55%,
control = 33%; p = 0.19).
22 ? Y Grigoras et al.,
2012
Lidocaine 1.5 mg/kg
intravenous bolus
and infusion versus
saline infusion
M 36 + Intravenous lidocaine reduced rest pain VAS 4 h post-operatively
(lidocaine = 11.8, control = 29.5; p = 0.012). However, lidocaine had
no signiﬁcant impact on VAS at rest or with movement at any other
assessments during the ﬁrst post-operative week.
At 3 months, lidocaine signiﬁcantly reduced the incidence of chronic
pain (lidocaine = 11.8%, control = 47.4%; p = 0.031), the intensity of
pain (lidocaine VAS = 2.6, control VAS = 14.6; p = 0.025) and the
area of hyperalgesia (lidocaine = 0.2 cm, control = 3.2 cm;
p = 0.002). Appears underpowered.
23 N Y Fassoulaki et al.
(2000)
EMLA cream 5 g
versus inactive
placebo cream
perioperatively for 5
days
M 45 + Eutectic mixture of local anaesthetic (EMLA) cream had no signiﬁcant
impact on acute pain VAS during the ﬁrst 6 days post-operatively
(data shown graphically).
At 3 months, the group that received EMLA had a statistically and
clinically signiﬁcantly reduced incidence of total chronic pain
compared to control (EMLA = 43%, control = 91%; p = 0.002).
24 Y Y Obata et al.
(1999)
Epidural mepivacaine
infusion
commenced 20 min
prior to surgery
versus at the end of
the operation
T 70 + Commencing the epidural prior to surgical incision caused a
signiﬁcant reduction in pain VAS at rest after 4 h post-operatively
and on the second and third post-operative days (data expressed in
graphical form only). Early epidural commencement offered no
signiﬁcant advantage for the rest of the ﬁrst post-operative week.
There was no difference in NSAID use between groups during the
ﬁrst week.
At 6 months, commencing the epidural prior to surgical incision
signiﬁcantly reduced the incidence of chronic pain compared with
commencing at the end of the operation (epidural before = 33%,
epidural after = 67%; p = 0.01). No control arm without epidural.
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Table 1 (continued)
Δ Ac Δ Chr Study Intervention Op Size RoB Outcomes
25 Y Y Senturk et al.
(2002)
PCA versus epidural
pre- or post-surgical
procedure
T 69 − Commencing the epidural prior to surgical incision caused a
statistically and clinically signiﬁcant reduction in pain VNRS at rest,
with movement and with coughing during the ﬁrst 48 h
post-operatively compared with the other two groups: late epidural
commencement and intravenous patient-controlled analgesia (i.v.
PCA).
At 6 months, commencing the epidural prior to surgical incision was
associated with the lowest incidence of chronic pain and this was
statistically and clinically signiﬁcant (epidural before = 45%, epidural
after = 63%, i.v. PCA = 78%; p < 0.05 between early epidural and i.v.
PCA). Patients not blinded to group allocation (although clinicians
are reported to be blinded). Therefore plausible bias that raises
some doubts about the results. Appears underpowered.
26 N N Ochroch et al.
(2002)
Epidural analgesia
commenced prior
to incision or at the
end of operation
T 157 ? Commencing the epidural prior to surgical incision had no signiﬁcant
impact on pain VAS during the ﬁrst 5 post-operative days (data
displayed graphically), but it did have an epidural sparing effect
(epidural before = 499 mL, epidural after = 622 mL; p = 0.035).
At 11 months, commencing the epidural prior to surgical incision
appeared to offer no signiﬁcant beneﬁt over commencing the
epidural at the end of the operation but before reversal of general
anaesthesia (data only shown graphically). Signiﬁcant gender
imbalance between groups (epidural before 61% women, epidural
after = 43% women; p = 0.047). Authors also demonstrate
signiﬁcantly worse BPI pain scores for women in general in this
setting (data displayed graphically). Therefore plausible bias that
raises some doubts about the results.
27 N Y Salengros et al.
(2010)
Presurgical epidural
and low-dose
intraoperative
remifentanil infusion
versus post-surgical
epidural and
high-dose
intraoperative
remifentanil infusion
T 38 + Commencing the epidural prior to surgical incision and using the
lower concentration remifentanil infusion intraoperatively had no
impact on acute pain VNRS total aggregate scores during hospital
stay either at rest or with movement. Commencing the epidural
prior to surgical incision and using the lower concentration
remifentanil infusion intraoperatively caused a statistically and
clinically signiﬁcant reduction in the surface area of chest wall
allodynia during the ﬁrst 3 post-operative days and also one month
later (data only shown graphically).
At 9 months, commencing the epidural prior to surgical incision and
using the lower concentration remifentanil infusion appeared to
signiﬁcantly reduce the incidence of chronic pain (epidural
before = 16.7%, epidural after = 70%; p = 0.009) and also the mean
chronic pain intensity (epidural before VNRS = 0.72, epidural after
VNRS = 1.6; p = 0.013). Did not have a 3rd control arm without
epidural. Appears underpowered.
28 – N Nikolajsen et al.
(1997)
Epidural bupivacaine
and morphine prior
to amputation
versus epidural
saline with
intramuscular or
oral morphine
A 60 ? Acute pain not described in speciﬁc detail.
At 12 months, epidural analgesia had no signiﬁcant impact on the
incidence of phantom limb pain (epidural = 75%, control = 69%;
p = 1.0) or the intensity of phantom or stump pain VAS in these
vasculopaths (epidural: phantom = 20 mm, stump = 0 mm, control:
phantom = 9 mm, stump = 4 mm; p > 0.05). Appears
underpowered and epidural group had higher median pain VAS and
higher opioid consumption prior to operation, therefore plausible
bias that raises some doubts about the results.
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Gabapentin did not reduce acute pain in two trials
where epidural analgesia was used for amputation or
thoracotomy, respectively (Nikolajsen et al., 2006;
Kinney et al., 2012). In the former, therapeutic doses
of gabapentin were used, but the patients had chronic
pain preoperatively secondary to vascular disease. In
the latter, only a single dose of gabapentin was given
perioperatively. The antidepressant venlafaxine
(37.5 mg) was associated with significantly lower
post-mastectomy pain after 7 days, and after 6
months, the incidence of post-mastectomy burning
and stabbing pain was significantly lower (Amr and
Yousef, 2010).
3.3.2 Ketamine
In one trial, intravenous ketamine infusion signifi-
cantly reduced acute pain after thoracotomy but did
not reduce chronic pain (Dualé et al., 2009). In three
trials, intravenous ketamine had no impact on acute
or chronic pain with or without the presence of epi-
dural analgesia for amputation or thoracotomy (Hayes
et al., 2004; Joseph et al., 2012; Mendola et al., 2012).
Epidural ketamine was co-administered with
bupivacaine in two trials. In one of these, ketamine
reduced acute pain but not chronic pain (Wilson et al.,
2008), and in the other trial, acute pain was not
Table 1 (continued)
Δ Ac Δ Chr Study Intervention Op Size RoB Outcomes
29 Y Y Kairaluoma et al.
(2006)
Paravertebral block
versus sham block
M 60 + Paravertebral block caused a signiﬁcant reduction in the number of
patients reporting pain VAS greater than 3 out of 10 during the ﬁrst
2 post-operative weeks (data only shown graphically).
At 12 months, paravertebral block signiﬁcantly reduced the
prevalence of chronic pain (paravertebral block = 43%,
control = 77%; p = 0.008) and the intensity of pain VNRS with
movement (paravertebral block VNRS = 0, control VNRS = 2;
p = 0.003).
30 N Y Ibarra et al. (2011) General anaesthesia
± paravertebral
block
M 40 − Paravertebral block had no signiﬁcant impact on acute pain VAS with
movement compared to control (paravertebral block VAS: at
60 min = 3, at 24 h = 2.3; control VAS: at 60 min = 2.9, at
24 h = 2.8; p = NS).
At 5 months, paravertebral block signiﬁcantly reduced the prevalence
of chronic pain (paravertebral block = 6.7%, control = 50%; p = 0.01).
Underpowered. High proportion lost to follow-up. Unclear risk of
bias for multiple domains.
31 Y Y Karanikolas et al.
(2011)
RCT with ﬁve trial
arms examining
effect of different
regimes
incorporating
perioperative
epidural or fentanyl
PCA versus
‘conventional
analgesia’
A 65 + Complex trial with 5 treatment arms including combinations epidural,
i.v. PCA and control analgesia. The best post-operative VAS scores
at 24 h were in the patients that received epidural pre-, during and
post-amputation and those that had general anaesthesia with a
PCA pre- and post-operatively (Epi/Epi/Epi = 0, PCA/Epi/Epi = 22.5,
PCA/Epi/PCA = 17.5, PCA/GA/PCA = 0, control analgesia = 50;
p = 0.001).
At 6 months, the prevalence of chronic pain was lowest in the
patients that received epidural pre-, during and post-amputation
(Epi/Epi/Epi = 7.7%, PCA/Epi/Epi = 30.7%, PCA/Epi/PCA = 58.3%,
PCA/GA/PCA = 23%, control analgesia = 75%; p = 0.004). Appears
underpowered due to 5 treatment arms.
32 N Y Song et al. (2012) Thoracic epidural with
total intravenous
anaesthesia versus
thoracic epidural
with inhalational
anaesthesia
T 343 + Total intravenous anaesthesia (TIVA) with propofol and remifentanil
had no impact on acute pain VRNS after thoracotomy compared to
inhalational anaesthesia with sevoﬂurane.
At 6 months, the group that received TIVA had a statistically and
clinically signiﬁcant reduced incidence of chronic pain
(TIVA = 33.5%, 50.6%, p = 0.002).
Randomized controlled trials (RCTs) are listed according to the type of intervention.
‘?’, unclear risk of bias for one or more key domains; ‘−’, high risk of bias for one or more key domains; ‘+’ low risk of bias for all key domains; Δ,
potentially beneﬁcial effect; A, amputation; Ac, acute; Chr, chronic; M, mastectomy; NSAIDs, non-steroidal anti-inﬂammatory drugs; Op, operation;
PCA, patient-controlled analgesia; RoB, Cochrane Collaboration Risk of Bias; T, thoracotomy; VAS, visual analogue scale; VNRS, verbal numerical rating
score.
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assessed, but the drug had no impact on chronic pain
(Ryu et al., 2011).
3.3.3 Cryoanalgesia
In one trial of thoracotomy patients, intercostal
cryoanalgesia reduced acute pain versus control
therapy (no epidural; Sepsas et al., 2013). In the same
trial, there was a difference in pain scores at 2 months
that was statistically significant, but not clinically sig-
nificant (VAS: 0.0/10 vs. 0.25/10). However, in a
further five thoracotomy trials, cryoanalgesia had no
impact on acute pain (Gwak et al., 2004; Yang et al.,
2004; Ju et al., 2008; Mustola et al., 2011; Lu et al.,
2013). Of these five thoracotomy trials, intercostal
cryoanalgesia had no impact on chronic pain in one
trial (Gwak et al., 2004) and actually increased
chronic pain in four trials (Yang et al., 2004; Ju et al.,
2008; Mustola et al., 2011; Lu et al., 2013).
3.3.4 Local anaesthetic
Six trials investigated the effect of local anaesthetics.
Ropivacaine infiltration reduced acute pain for 1.5 and
6 h, respectively, in two trials (Vigneau et al., 2011;
Albi-Feldzer et al., 2013), but had no impact on the
development of chronic post-mastectomy pain. In a
third ropivacaine trial, the drug had no impact on
acute or chronic pain (Baudry et al., 2008). Lidocaine
infiltration also had no impact on acute or chronic
pain in thoracotomy patients (Cerfolio et al., 2003),
whereas in one trial, intravenous lidocaine infusion
Table 2 Cochrane Collaboration Risk of Bias assessment summary.
Study
Sequence
generation
Allocation
concealment
Blinding of
participants and
personnel
Blinding of
outcome
assessment
Incomplete
outcome data
Selective
reporting Other bias
Overall risk
of bias
1 Fassoulaki et al. (2002) + + + + + ? + +
2 Fassoulaki et al. (2005) + + + + + ? + +
3 Nikolajsen et al. (2006) + + + + ? ? ? ?
4 Kinney et al. (2012) + + + + ? ? + ?
5 Amr and Yousef (2010) + + + + ? ? + ?
6 Dualé et al. (2009) + + + + ? + + +
7 Hayes et al. (2004) + + + + + ? + +
8 Mendola et al. (2012) + + + + + ? + +
9 Joseph et al. (2012) + + + + ? + + +
10 Wilson et al. (2008) + + + + ? + + +
11 Ryu et al. (2011) + + + + ? + + +
12 Ju et al. (2008) ? + + + ? ? + ?
13 Yang et al. (2004) + + + + ? ? + ?
14 Mustola et al. (2011) ? + + + ? ? + ?
15 Sepsas et al. (2013) ? + + + ? ? ? ?
16 Gwak et al. (2004) ? + + + ? ? + ?
17 Lu et al. (2013) + + + + + ? + +
18 Cerfolio et al. (2003) ? + + + + ? + +
19 Vigneau et al. (2011) + + + + + ? + +
20 Albi-Feldzer et al. (2013) + + + + + ? + +
21 Baudry et al. (2008) + + + + ? ? + ?
22 Grigoras et al. (2012) + + + + + ? + +
23 Fassoulaki et al. (2000) ? + + + + ? + +
24 Obata et al. (1999) ? + + + + ? + +
25 Senturk et al. (2002) ? − − + + ? + −
26 Ochroch et al. (2002) ? + + + + ? + ?
27 Salengros et al. (2010) ? + + + + ? + +
28 Nikolajsen et al. (1997) ? + + + ? ? ? ?
29 Kairaluoma et al. (2006) + + + + + ? + +
30 Ibarra et al. (2011) ? + ? + − ? + −
31 Karanikolas et al. (2011) + + + + + + + +
32 Song et al. (2012) + + + + + ? + +
‘+’, low risk of bias (unlikely to seriously alter the results); ‘?’, unclear risk of bias (raises some doubt about the results); ‘−’, high risk of bias (seriously
weakens conﬁdence in the results). The far right column (in bold) gives overall risk of bias based on all the values within an entire row.
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(1.5 mg/kg pre- and intraoperative) had no impact on
acute pain overall, but significantly reduced the inci-
dence chronic pain and the area of hyperalgesia
(Grigoras et al., 2012). In another trial, topical EMLA
cream applied (for 5 days) had no impact on acute
pain, but it reduced the incidence of chronic pain after
mastectomy (Fassoulaki et al., 2000).
3.3.5 Regional anaesthesia, remifentanil
and propofol
Seven trials investigated the acute and chronic impact
of regional anaesthesia including whether it could
have a beneficial pre-emptive effect. One study found
that although epidural analgesia was effective in the
acute perioperative setting, it did not reduce chronic
phantom limb pain in patients who had chronic pain
preoperatively secondary to vascular disease
(Nikolajsen et al., 1997). In contrast, two trials found
that epidural analgesia reduced acute and chronic pain
versus control therapy after thoracotomy and ampu-
tation, respectively (Senturk et al., 2002; Karanikolas
et al., 2011). Four trials examined whether the timing
of epidural analgesia could impact on acute and
chronic pain (Obata et al., 1999; Ochroch et al., 2002;
Senturk et al., 2002; Karanikolas et al., 2011). One of
these trials found that it made no difference to acute or
chronic pain whether the epidural was commenced
immediately before or after the thoracotomy proce-
dure (Ochroch et al., 2002). In contrast, the remaining
three trials found that the optimization of analgesia
preoperatively had a beneficial impact on both acute
and chronic pain (Obata et al., 1999; Senturk et al.,
2002; Karanikolas et al., 2011). Two trials of mastec-
tomy patients investigated preoperative paravertebral
block. The first trial found that paravertebral block
significantly reduced acute pain and chronic pain 1
year later compared with sham block (Kairaluoma
et al., 2006). The second trial found that paravertebral
block had no significant impact on acute pain, but
reduced the prevalence of chronic pain, compared
with control (Ibarra et al., 2011). One trial compared
preoperative epidural commencement with low-dose
intravenous remifentanil infusion versus post-
operative epidural commencement with a high-dose
intravenous remifentanil infusion for thoracotomy
patients (Salengros et al., 2010). They found no differ-
ence in acute pain, but high-dose remifentanil with a
post-operative epidural was associated with a higher
incidence of chronic pain. In addition, they found that
the surface area of chest wall allodynia was signifi-
cantly larger for the high-dose remifentanil group
during the first post-operative month.
A single large trial of thoracotomy patients receiving
thoracic epidurals compared TIVA with propofol and
remifentanil against inhalational anaesthesia with
sevoflurane (Song et al., 2012). There was no differ-
ence in acute pain between the two groups, but the
incidence of chronic pain was significantly reduced at
3- and 6-month assessments in the TIVA group.
4. Conclusions
4.1 Principal ﬁndings
Gabapentinoids, antidepressants, local anaesthetics
and regional anaesthesia have the potential to reduce
the severity of both acute and chronic pain for patients
undergoing amputation, thoracotomy or mastectomy.
Ketamine and cryoanalgesia do not appear to be
promising agents for reducing chronic pain. TIVA with
propofol may have the potential to reduce the inci-
dence of chronic pain, whereas the effect of opioids
such as remifentanil is unclear.
4.2 Overview of ﬁndings and limitations
This systematic review was limited to amputation,
mastectomy and thoracotomy because these opera-
tions are considered to be associated with a combina-
tion of nociceptive and neuropathic symptoms and
carry a high risk of chronic pain. If it is accepted that
the severity of acute pain is correlated with the risk of
developing chronic pain, then it follows that the peri-
operative period is a logical target for interventions
aimed at reducing or preventing the phenomenon.
The positive and the negative results of this review are
both important to guide future clinical practice. Spe-
cifically, it is useful to note the ineffective or harmful
therapies so that they may be avoided and further
trials of them may also be avoided.
The trials included in this systematic review were of
varying quality, but addressed the majority of conven-
tional methodological standards. However, the hetero-
geneity of the trial methodology and outcome
measures ruled out the performance of a meaningful
meta-analysis. Despite the lack of consistency and
comparability between trials, several consistent
themes emerge in the results. Acute pain in the peri-
operative period after amputation, mastectomy and
thoracotomy appears to be a mix of nociceptive and
neuropathic pain. The acute neuropathic component
is potentially responsive to agents that work on neu-
ropathic symptoms, but not nociceptive symptoms.
The acute neuropathic component may be relatively
resistant to conventional analgesics, but is potentially
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treatable, and if the correct intervention is utilized in
the correct manner (dose/duration/timing), it has the
potential to reduce the development of chronic pain.
A number of trials included in this review studied a
single, brief intervention, which was typically not
enough to achieve long-term benefits, potentially due
to the fact that the process of neuroplasticity that can
continue for days or weeks post-operatively. The days
following an operation appear to be as important as
the day of the operation itself, i.e., the potential ben-
efits of a pain-free initial 12 h could be made obsolete
if the pain is severe thereafter. Furthermore, neuro-
pathic symptoms may take several days to manifest
post-operatively, thus emphasizing the importance of
recognition and referral to a vigilant and cognizant
acute pain service.
4.3 Comments on speciﬁc interventions
4.3.1 Gabapentinoids, antidepressants
There were mixed results for the gabapentinoids; these
agents reduced acute post-operative pain unless an
effective epidural was present, in which case no sig-
nificant difference was observed. Within the trials,
gabapentinoids were often given once only or at sub-
therapeutic doses. However, if an appropriate thera-
peutic dose was administered for a longer period of
time, the efficacy appeared greater. This is in keeping
with other studies of acute post-mastectomy pain
reported in the literature (Dirks et al., 2002; Grover
et al., 2009; Kim et al., 2011). Of note, vascular
patients with chronic pain preoperatively continued to
have chronic pain post-operatively despite gabapen-
tin. Separately, the antidepressant venlafaxine was
associated with enhanced analgesia 1 week after mas-
tectomy and after 6 months despite being adminis-
tered at the potentially sub-therapeutic dose of
37.5 mg.
4.3.2 Local anaesthetics and regional anaesthesia
Interpretation of the trials examining the potential
benefits of regional analgesia as a single group was
challenging due to the inherent heterogeneity of trial
methodology. Effective regional techniques in the
hands of skilled clinicians can ablate the peak noxious
barrage (Bonhomme et al., 2006; Wennervirta et al.,
2008) of pain in the perioperative period and poten-
tially minimize pathological neural plasticity impli-
cated in the genesis of chronic pain (Woolf and Salter,
2000; Scholz and Woolf, 2007; Harvey and Dickenson,
2008; Ivani et al., 2008). Unsurprisingly, the majority
of the trials included in this review found regional
analgesia to be beneficial for reducing perioperative
pain and subsequent chronic symptoms. The single
trial that found epidural analgesia to be no better than
standard analgesia comprised vascular patients with
pre-existing chronic pain prior to amputation. It is
perhaps unsurprising that a few days of epidural anal-
gesia did not impact on the chronic symptomatology
of these vasculopaths. Several trials examined the
timing of regional intervention. In particular, the
complex trial by Karanikolas et al. (2011) indicated
the benefits of early epidural insertion and continued
infusion for the entire perioperative period. However,
the same trial also found that if patients were managed
aggressively and effectively with systemic opioids, an
acceptable outcome could also be achieved. Early
commencement of regional analgesia may offer some
benefits for post-operative pain and may have other
advantages such as facilitation of balanced anaesthe-
sia, minimization of sympathetic stress on the cardio-
vascular system and potential reduction of blood loss.
They are also particularly useful in patients who are
opioid tolerant. Optimal duration of regional analgesia
is yet to be determined and potential benefits may be
lost if epidural infusions are discontinued too early for
logistical reasons.
Infiltration of local anaesthetic could provide a brief
period of analgesia, but did not impact on the risk of
developing chronic pain. In contrast, intraoperative
intravenous lidocaine and perioperative EMLA cream
reduced the incidence of chronic pain following mas-
tectomy, without making a significant impact on acute
pain.
4.3.3 Remifentanil and propofol
Remifentanil infusions have become a popular com-
ponent of balanced anaesthesia for a multitude of sur-
gical procedures. However, the theoretical concept of
opioid-induced hyperalgesia appeared to be confirmed
in a relevant clinical setting in the trial by Salengros
et al. (2010). Indeed, high-dose intraoperative
remifentanil was also associated with an increased risk
of chronic post-surgical pain. In contrast, TIVA with
propofol and remifentanil was associated with a
reduced incidence of chronic post-thoracotomy pain
than inhalational anaesthesia with sevoflurane (Song
et al., 2012). Given the phenomenon of opioid-
induced hyperalgesia (Ballantyne and Mao, 2003;
Angst and Clark, 2006; Raghavan et al., 2011), the
potential benefit of TIVA is more likely to be propofol-
mediated, potentially via glutamate, GABAA and
glycine receptors (Song et al., 2012).
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4.3.4 Ketamine and cryoanalgesia
While ketamine is an effective co-analgesic agent for
acute pain and has the advantage that it may be used
by patients in whom the oral route is unavailable, it
did not reduce the risk of chronic post-surgical pain
and its use in general is limited by dysphoric side
effects. Ketamine also offered no additional benefit in
the presence of effective epidural analgesia. Of even
greater concern is intercostal nerve cryoanalgesia,
which could arguably be renamed as ‘cryoneuralgia’
and perhaps be considered as an adjunctive therapy
only in the setting of palliative care.
4.3.5 Implications for clinical practice
Current mainstream perioperative management for
amputation, thoracotomy and mastectomy is highly
variable, but the choices that anaesthetists make may
have long-term implications for patients under their
care. Standard practices that rely primarily on opioids
and NSAIDs for perioperative analgesia may be inad-
equate for patients at risk of neuropathic pain. Sepa-
rately, techniques such as cryoanalgesia should be
avoided. Gabapentinoids and antidepressants (which
are not considered to be effective for nociceptive
symptoms), as well as local anaesthetics and regional
anaesthesia, may potentially reduce the severity of
both acute and chronic pain for patients undergoing
operations associated with a high risk of chronic post-
surgical pain. However, some pharmacological agents
may take a number of hours to be of benefit and
therefore therapeutic dosages should be used for
several weeks in many instances.
There have been promising results for the use of
gabapentinoids in other conditions (Brogly et al.,
2008; Buvanendran et al., 2010; Gray et al., 2011) but
anti-neuropathic pain drugs have not been proven to
be beneficial for surgical interventions that are pre-
dominantly associated with nociceptive pain such as
minor gynaecological procedures. Cases of neuro-
pathic pain may be discovered using simple screening
tools routinely, e.g., DN4 or LANSS (Bennett, 2001;
Bouhassira et al., 2005), and by identifying those who
are experiencing a disproportionate level of pain.
Appropriate interventions at this stage may provide
superior analgesia and facilitate optimum recovery.
Not all cases of chronic post-surgical neuropathic pain
may be prevented, but the risk may be reduced. This
may decrease the burden on society and the amount
of financial resources spent on the management of
chronic pain syndromes.
4.3.6 Implications for future research
Future trials in this field should focus on conditions
with a high risk of neuropathic pain, e.g., amputation,
thoracotomy and mastectomy. They should use appro-
priately high dosages of medications, and therapy
could commence prior to surgery and continue for
several weeks. Patient follow-up should be for a
minimum of 6 months and a much more comprehen-
sive and multidimensional assessment made of the
character and severity of pain at rest and movement
with an emphasis on level of function and basic neu-
rophysiological testing (Melzack, 1987; Wilder-Smith
et al., 2003; Kehlet and Rathmell, 2010; Wildgaard
et al., 2011).
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